Sign In

Gilles Alberici

Président OCTALFA et Fonds de Dotation Dominique & Tom Alberici

Gilles Alberici is a prominent figure in the pharmaceutical industry with over 35 years of experience, particularly in the development of drugs for rare diseases. He currently serves as the Executive Chairman of ORPHELIA Pharma, a French company specializing in pediatric medicines.13

Career Highlights

  • Founder and President of initiative OCTALFA, a family-owned organization that invests in life sciences companies12
  • Founder of OPi, Pharmaceuticals for Rare Diseases2
  • Chairman of the Board at ORPHELIA Pharma (appointed in 2015)13
  • Involved with OREGA Biotech

Experience and Expertise

Gilles Alberici has a deep understanding of pharmacology and drug development for rare diseases. He has been instrumental in taking more than ten products through clinical trials.2 His expertise spans various areas of the pharmaceutical and biotechnology sectors, including:

  • Drug formulation development for pediatric indications
  • Neurology and metabolic diseases
  • Immuno-oncology

Education and Early Career

Alberici studied at Université Paris Sud (Paris XI) and has worked with organizations such as Gustave Roussy, Institut Mérieux, and IMTIX.

Current Roles

  • Executive Chairman at ORPHELIA Pharma13
  • President of OCTALFA2
  • President of Fonds de Dotation Dominique & Tom Alberici

Achievements at ORPHELIA Pharma

Under Alberici's leadership, ORPHELIA Pharma has made significant strides in developing pediatric formulations of existing drugs. The company has been working on several projects, particularly in the field of epilepsy, and has been utilizing European regulations on pediatric medicines to bring new treatments to market.1

Gilles Alberici's extensive experience and leadership have been crucial in driving ORPHELIA Pharma's mission to develop and commercialize innovative pediatric medicines, addressing unmet needs in areas such as neurology and rare diseases.

Highlights

Jul 12 · linkedin

It is published! Read the 17th issue of the @fondation alberici newsletter. During this first half of the year -in part thanks to your donations- our Endowment Fund and OCTALFA Corporate Foundation @fondation alberici were able to support 13 well-designed projects whose details you will find in our newsletter link:  https://lnkd.in/eAeSEnr8

Thank you all for supporting us and the projects aiming at improving quality of life for disabled people and cancer patients. Happy reading and happy summer! https://lnkd.in/g-r9HrY

L'AppelCentre Léon Bérard Association Zicomatic Fédération Cheer Up Association Quelle Histoire !
ACADEMIE DE CUIVRES EN DOMBES Les PEP 18 La Passerelle Ouest

Edith de RotalierJean-Yves Blay, Hélène Grevot Graziella Greslin, DEBORA Di Gilio, Celine Hooge-Jullien, Nora TAOURIRT DUMAS, Clara Brabet, Ambroisine Gossart, Jessy Meneteau, Juncker Christian, Emmanuèle Gerdil,Julien ALBERICI, Henri Montes , Pascale VIVION, Clément Dumon, Céline Dumon, Choffardet Sandrine Annelise UHLRICH, Morgann Matho,Marie-Bernard COUTURE,RAZAFIMBELO Andoniaina Thierry Abribat Christophe Debat   #handicap #inclusion #cirque #MADAGASCAR

Dec 18 · linkedin

Dear all, the 16th issue of the Fondation Alberici newsletter has already arrived! You will find news of our programs in Madagascar, a short summary of some projects supported in the 2nd half of 2023 and an update of our call for projects #FAOMA. There is also a focus on one of the laureates of #FAOMA – a project for a foster home for parents of elderly children with disabilities AGEPA. Enjoy your reading. Thank you again for your support, whether in the form of donations or relaying our communications. It is very useful to us. Happy Christmas and New Year!

Read our newsletter in English : https://lnkd.in/dAywU3gd

A big thank you to our Board members Thierry Abribat, Juncker Christian, Henri Montes, Julien ALBERICI, Emmanuèle Gerdil, Gilles Alberici

Related Questions

What are Gilles Alberici's main achievements at ORPHELIA Pharma?
How did Gilles Alberici's background influence his role at ORPHELIA Pharma?
What is the significance of the PUMA regulation for ORPHELIA Pharma's projects?
How does initiative OCTALFA support ORPHELIA Pharma's development activities?
What are the main projects currently in clinical development at ORPHELIA Pharma?
Gilles Alberici
Gilles Alberici, photo 1
Gilles Alberici, photo 2
Add to my network

Location

Écully, Auvergne-Rhône-Alpes, France